Medicus Pharma has submitted a streamlined Phase 2b/3 trial design to the FDA for Teverelix, a long-acting GnRH antagonist targeting advanced prostate cancer patients at increased cardiovascular risk. The new trial design combines dose optimization, androgen suppression, and cardiovascular evaluation into a single stage, reducing the patient number from about 1,500 to 600. This approach aims to speed up the registration process and prepare Teverelix for strategic partnership or licensing, as Medicus plans not to fund the study themselves. The company expects to complete clinical readiness steps by year-end and awaits FDA feedback on the protocol.
Medicus Pharma's prostate cancer trial update is provided here with Pluang's health sector snapshot as of Sep 29, 2026 19:14 WIB: Among 100 priced US health stocks, 50 rose and 41 fell today. Notable movers include CTXR at USD 0.57 with a 3.28% gain and 100% buy order activity, ABCL at USD 14.28 with a 2.59% gain and 71% buy order activity, and HRTX at USD 0.28 with a 5.17% loss and 60% sell order activity.
Bitcoin recently closed above its 50-week moving average for the first time since last November, breaking out of a long trading range. The critical test now is whether Bitcoin can hold the $82,500 level, which will influence the direction of XRP and ...
Moca Network and Moca Foundation launched the Moca Chain mainnet on September 29, introducing a blockchain designed for portable digital identity and privacy-preserving verification. This new network allows users to carry verified credentials like id...
Carnival's Q3 2026 earnings report showed revenue and adjusted EPS beating analyst estimates, driving its stock up 12%. This positive result lifted shares of Royal Caribbean and Norwegian by 7% and 5% respectively, even without their own news. The ra...
ChatGPT predicts XRP may trade at $1.85 following Ripple's completion of its 2026 escrow releases, implying a 22% increase from its current $1.52 price. Ripple plans to unlock 3 billion XRP between October and December 2023, but most tokens are expec...
Arista Networks plays a crucial role in AI infrastructure by providing high-speed networking equipment that links GPUs for major cloud providers like Microsoft and Meta. Since 2021, Arista's earnings have surged, resulting in a 56.99% year-to-date to...
